Available Dexcom CGM products include: Dexcom G6 (adults and children 2 years and ... specific health needs, and cost.

In what makes Abbott Laboratories a serious competitor is the much lower price one has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's Guardian.

Second, Dexcom's latest, the G7, can be manufactured at significantly lower-cost, which offers flexibility ... and faster warm-up time than G6. Medicare's decision to reimburse for the G6 and ...

Its innovative devices like the G6 and ... pricing and cost pressures possibly driven by competition, as well as innovations in related medical fields. Despite these challenges, DexCom maintained ...

A class action lawsuit was filed against DexCom, Inc. (DXCM ... the gross margin guidance reflected the conversion from the G6 to the G7 CGM model. Additionally, during the Q1 FY24 report ...

DexCom's Q2 earnings report was disastrous, revealing internal sales channel issues and competitive pressures, leading to a Hold rating and lowered price targets. The company's reliance on channel ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...

Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices Commodities ...

DexCom (NASDAQ:DXCM) reported third-quarter earnings that surpassed analyst expectations, but the company's stock plummeted 16% as revenue growth slowed significantly. The continuous glucose ...

DexCom (DXCM) reported $994.2 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 2%. EPS of $0.45 for the same period compares to $0.50 a year ago.